AI Digital Care Support Agents

AI digital care support agents connect to telemedicine patient portals—like those in Mend, Amwell, or Teladoc—via secure APIs and webhooks. They operate on key patient data objects: appointment records, care plans, medication lists, and messaging threads. The agent's primary surfaces are the post-visit follow-up module, the patient messaging center, and the care plan dashboard, where it can trigger personalized, context-aware interactions based on scheduled events or patient-initiated queries.

Implementation typically involves a middleware layer that subscribes to platform events (e.g., visit.completed, plan.updated) and uses orchestration logic to dispatch appropriate AI workflows. For example, after a visit for hypertension, the agent can be configured to:

• Send a treatment plan summary via the portal's messaging API.
• Initiate a medication reminder sequence three days later.
• Answer FAQ-style questions (e.g., "Can I take this medication with food?") using a RAG system grounded in the patient's specific plan and general clinical guidelines.
• Escalate complex or high-risk queries to a human care coordinator by creating a support ticket in the platform's task queue.

Rollout requires a phased, condition-specific approach, starting with high-volume, low-risk workflows like post-visit instructions and appointment reminders. Governance is critical: all agent responses should be logged to an audit trail linked to the patient record, and prompts must be engineered to operate within a strict clinical guardrail, avoiding diagnostic advice. A human-in-the-loop review step should be maintained for all new message templates and escalation workflows before full automation.

The integration connects to the telemedicine platform's patient messaging APIs and FHIR-compliant data endpoints (e.g., Patient, CarePlan, Appointment). An AI agent, hosted in a private Inference Systems VPC, listens for events such as new portal messages, appointment reminders, or care plan updates. The agent uses a retrieval-augmented generation (RAG) pipeline, querying a dedicated vector store populated with anonymized, de-identified FAQ documents, condition-specific educational materials, and institutional protocols. This ensures responses are grounded in approved content, not generated from scratch.

For each patient interaction, the system executes a secure workflow: 1) The platform event (e.g., a patient question in the Mend portal) triggers a webhook to our orchestration layer. 2) The layer enriches the request with relevant, permissible patient context (e.g., upcoming appointment time, medication list from the last visit) fetched via a scoped API call. 3) The AI agent processes the query, and its proposed response is logged to an immutable audit trail before delivery. 4) The final response is posted back to the patient's message thread via the platform's API, maintaining the native user experience. For escalations, the agent can create a support ticket or flag a care coordinator using the platform's internal tasking system.

Governance is designed for clinical environments. All data in transit and at rest is encrypted. The system operates under a strict zero-data-persistence policy for Protected Health Information (PHI) within the AI runtime; PHI is held ephemerally in memory only for the duration of the request. Access is controlled via the platform's existing RBAC, and all agent actions are written to the platform's audit log. Rollout follows a phased approach: starting with non-clinical FAQs and reminders, then gradually expanding to treatment plan adherence support after validation and clinician approval. Human-in-the-loop review steps are configured for all new message types during the pilot phase.

Implementation begins by mapping the agent's tool-calling permissions to specific, read-only surfaces within the patient portal (e.g., Mend's appointment API, care plan objects, secure messaging queue). Initial agents are configured for low-risk, high-volume workflows like sending medication reminders, answering FAQ about clinic hours, or collecting pre-visit intake data via structured forms. All agent-patient interactions are logged to a dedicated audit table with trace IDs, and any escalation to live staff triggers a handoff event that includes the full conversation context.

A phased rollout is critical. Phase 1 targets a single care pathway (e.g., post-operative recovery for a specific procedure) and a pilot patient cohort. The AI agent operates in a shadow mode or co-pilot mode for the first 30 days, where its suggested messages and actions are reviewed by a care coordinator before being sent. This generates a validation dataset and refines the guardrails. Phase 2 enables autonomous operation for the validated pathway while adding a second condition (e.g., chronic disease management for diabetes). Governance is maintained through a weekly review of interaction logs by clinical leadership, focusing on accuracy, patient sentiment, and any escalations.

Safety is engineered into the architecture. A pre-flight moderation layer scans all generated patient communications for clinical risk keywords (e.g., symptom descriptions, urgent requests) and routes those threads to human triage. The agent's knowledge is grounded in approved patient education materials and clinic policies via a RAG system connected to your document management platform, preventing hallucination. Access to PHI is strictly controlled through the telemedicine platform's native RBAC, and all data used for inference is ephemeral unless an audit log is required. This controlled, stepwise approach de-risks the integration and builds organizational trust, turning the AI agent from an experiment into a reliable extension of your care team.